1152 related articles for article (PubMed ID: 25762136)
1. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in the gene body influences MeCP2-mediated gene repression.
Kinde B; Wu DY; Greenberg ME; Gabel HW
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
4. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
5. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes.
Boxer LD; Renthal W; Greben AW; Whitwam T; Silberfeld A; Stroud H; Li E; Yang MG; Kinde B; Griffith EC; Bonev B; Greenberg ME
Mol Cell; 2020 Jan; 77(2):294-309.e9. PubMed ID: 31784358
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
8. Mecp2-null mice provide new neuronal targets for Rett syndrome.
Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
[TBL] [Abstract][Full Text] [Related]
9. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
10. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
14. Gene length matters in neurons.
Zylka MJ; Simon JM; Philpot BD
Neuron; 2015 Apr; 86(2):353-5. PubMed ID: 25905808
[TBL] [Abstract][Full Text] [Related]
15. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
17. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
[TBL] [Abstract][Full Text] [Related]
18. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
19. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
Giacometti E; Luikenhuis S; Beard C; Jaenisch R
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1931-6. PubMed ID: 17267601
[TBL] [Abstract][Full Text] [Related]
20. Neuronal non-CG methylation is an essential target for MeCP2 function.
Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]